The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,393,589 in first-year total cost, median $208,800.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]3
- Instrumentation and Systems Development Study Section[ISD]1
- Molecular Oncogenesis Study Section[MONC]1
- Special Emphasis Panel[ZRG1 OTC-B (02)]1
- Tumor Microenvironment Study Section[TME]1
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- DANA-FARBER CANCER INST1
- MAYO CLINIC ROCHESTER1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis1R21CA195665-01A1 | NAORA, HONAMI | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $208,800 | MONC |
| 2015 | Phosphoproteomic signatures for early detection and stratification of AML1R21CA188881-01A1 | KENTSIS, ALEXMARTO, JARROD A. | DANA-FARBER CANCER INST, MA | $228,678 | CBSS |
| 2015 | High-throughput immunoglobulin gene sequencing as a peripheral blood minimal residual disease assay to predict post-transplant relapse risk in multiple myeloma1R21CA195221-01 | LUNING PRAK, ELINE TJETSKESTADTMAUER, EDWARD A | UNIVERSITY OF PENNSYLVANIA, PA | $219,752 | CBSS |
| 2015 | Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes1R21CA195689-01 | NAORA, HONAMI | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $208,800 | TME |
| 2015 | Control of GVHD and Leukemia Relapse by Targeting Cell Metabolism1R21CA192202-01 | YU, XUE-ZHONG | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $195,098 | ZRG1 |
| 2014 | Individualized Peptide Monitoring for Plasma Cell Dyscrasias by Proteomics1R21CA187462-01 | BERGEN, HAROLD ROBERT | MAYO CLINIC ROCHESTER, MN | $207,495 | ISD |
| 2014 | The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma1R21CA182861-01A1 | BROWN, ELIZABETH ESANDERSON, RALPH D | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $124,966 | CBSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.